Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration. - Ahmed E; Goodchild C; Bisoukis A; Salvatore S (Clinical ophthalmology (Auckland, N.Z.), 2026)